Type 2 Diabetes Trial, Recruiting NCT06977230 Sponsor: Muğla Sıtkı Koçman University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06977230
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with type 2 diabetes and are currently receiving medical treatment for it
  • People who are scheduled for a planned (non-emergency) coronary artery bypass graft (CABG) heart surgery, with no other procedures planned at the same time
  • People whose overall health before surgery has been rated as Class III or IV by an anaesthesiologist (meaning they have serious but manageable health conditions)
  • People aged between 40 and 85 years

Who may not be able to join:

  • People who need emergency CABG surgery
  • People who have already had CABG surgery before and are having it again (revision surgery)
  • People whose heart pumping function is significantly reduced (confirm with trial site)
  • People with a history of cardiac arrest or cardiogenic shock (a serious condition where the heart suddenly cannot pump enough blood)
  • People who are pregnant
  • People with significant blood vessel disease affecting the arteries in their arms
  • People with liver problems, including certain abnormal blood test results related to liver function (confirm with trial site)
  • People with severe kidney disease or significantly reduced kidney function (confirm with trial site)
  • People currently taking the medications glibenclamide or nicorandil
  • People who have asthma

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00905054747098

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Muğla Sıtkı Koçman University
Registry
ClinicalTrials.gov
Start date
26 May 2025
Est. completion
30 July 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Postoperative 24-hour high-sensitivity Troponin T level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov